Nikesh Kotecha, PhD, currently serves as vice president of informatics at the Parker Institute for Cancer Immunotherapy. At PICI, Nikesh leads the informatics efforts to realize the institute’s mission to accelerate the development of breakthrough immune therapies to turn cancer into a curable disease.
His focus on delivering computational and molecular technologies to the healthcare community drives him to work at the intersection of medicine, informatics, entrepreneurship and education.
Prior to joining PICI, Dr. Kotecha was the CEO & Co-founder of Cytobank Inc. an analytics company building solutions around single-cell proteomics and cytometry, two technologies that are revolutionizing how we understand disease mechanism and have broad implications for treatments in cancer and autoimmunity. Inspiration for this project grew out of his work in Dr. Garry Nolan’s lab at Stanford University developing a diagnostic for juvenile myelomonocytic leukemia and on analysis methods for single-cell assays. Dr. Kotecha’s past experience also includes work at TIBCO Spotfire Inc. and Pfizer Inc. in multiple roles including engineering, technical sales and business development.
Dr. Kotecha is also a consulting faculty member in the Computational and Systems Immunology program at Stanford University and advisor at StartXMed, a Stanford startup accelerator.
His background and training include a doctorate in biomedical informatics from Stanford University, a bachelor of science degree in biomedical engineering from Boston University and over 15 years of experience building analytic applications to address scientific and informatics problems in healthcare.